Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designe... Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Mostra di più
| Periodo † | Var | Var % | Apert. | Max | Min | Med. Vol. Giorn. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.51 | -7.83410138249 | 6.51 | 7.0725 | 5.88 | 224849 | 6.28236953 | CS |
| 4 | -2.44 | -28.9099526066 | 8.44 | 8.55 | 5.88 | 212624 | 6.93120626 | CS |
| 12 | -7.04 | -53.9877300613 | 13.04 | 13.34 | 5.88 | 240062 | 9.29107841 | CS |
| 26 | -14.77 | -71.1121810303 | 20.77 | 23.33 | 5.88 | 369963 | 15.55570933 | CS |
| 52 | -32.7 | -84.496124031 | 38.7 | 61.9 | 5.88 | 360758 | 27.82166793 | CS |
| 156 | -6.6 | -52.380952381 | 12.6 | 61.9 | 2.11 | 943195 | 10.52343463 | CS |
| 260 | -134.4 | -95.7264957265 | 140.4 | 322.5 | 2.11 | 2140918 | 56.99367769 | CS |
| Nessuna Discussione Trovata |
| Crea Discussione |
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.
Assistenza: support@advfn.it
Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni
Caratteristiche principali
Premium
